Hao C - Search Results

1

The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin.

Wang Q, Wei F, Lv G, Li C, Liu T, Hadjipanayis CG, Zhang G, Hao C, Bellail AC. Wang Q, et al. Among authors: hao c. BMC Cancer. 2013 Nov 4;13:521. doi: 10.1186/1471-2407-13-521. BMC Cancer. 2013. PMID: 24182354 Free PMC article.

2

Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.

Song JH, Bellail A, Tse MC, Yong VW, Hao C. Song JH, et al. Among authors: hao c. J Neurosci. 2006 Mar 22;26(12):3299-308. doi: 10.1523/JNEUROSCI.5572-05.2006. J Neurosci. 2006. PMID: 16554480 Free PMC article.

3

Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells.

Song JH, Tse MC, Bellail A, Phuphanich S, Khuri F, Kneteman NM, Hao C. Song JH, et al. Among authors: hao c. Cancer Res. 2007 Jul 15;67(14):6946-55. doi: 10.1158/0008-5472.CAN-06-3896. Cancer Res. 2007. PMID: 17638906

4

Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells.

Wang P, Zhang J, Bellail A, Jiang W, Hugh J, Kneteman NM, Hao C. Wang P, et al. Among authors: hao c. Cell Signal. 2007 Nov;19(11):2237-46. doi: 10.1016/j.cellsig.2007.06.001. Epub 2007 Jun 21. Cell Signal. 2007. PMID: 17693058

5

TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges.

Bellail AC, Qi L, Mulligan P, Chhabra V, Hao C. Bellail AC, et al. Among authors: hao c. Rev Recent Clin Trials. 2009 Jan;4(1):34-41. doi: 10.2174/157488709787047530. Rev Recent Clin Trials. 2009. PMID: 19149761 Review.

6

DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.

Bellail AC, Tse MC, Song JH, Phuphanich S, Olson JJ, Sun SY, Hao C. Bellail AC, et al. Among authors: hao c. J Cell Mol Med. 2010 Jun;14(6A):1303-17. doi: 10.1111/j.1582-4934.2009.00777.x. Epub 2009 May 11. J Cell Mol Med. 2010. PMID: 19432816 Free PMC article.

7

Synergistic effect of celecoxib on TRAIL-induced apoptosis in hepatocellular carcinoma cells.

Lu G, Liu Y, Ji B, Wei F, Hao C, Wang G. Lu G, et al. Among authors: hao c. Cancer Invest. 2010 Jul;28(6):629-34. doi: 10.3109/07357900903095631. Cancer Invest. 2010. PMID: 20394499

8

Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment.

Lu J, McEachern D, Sun H, Bai L, Peng Y, Qiu S, Miller R, Liao J, Yi H, Liu M, Bellail A, Hao C, Sun SY, Ting AT, Wang S. Lu J, et al. Among authors: hao c. Mol Cancer Ther. 2011 May;10(5):902-14. doi: 10.1158/1535-7163.MCT-10-0864. Epub 2011 Mar 3. Mol Cancer Ther. 2011. PMID: 21372226 Free PMC article.

9

Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis.

Qi L, Bellail AC, Rossi MR, Zhang Z, Pang H, Hunter S, Cohen C, Moreno CS, Olson JJ, Li S, Hao C. Qi L, et al. Among authors: hao c. Apoptosis. 2011 Nov;16(11):1150-64. doi: 10.1007/s10495-011-0645-6. Apoptosis. 2011. PMID: 21877214 Free PMC article.

10

Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP.

Ding L, Yuan C, Wei F, Wang G, Zhang J, Bellail AC, Zhang Z, Olson JJ, Hao C. Ding L, et al. Among authors: hao c. Cancer Invest. 2011 Oct;29(8):511-20. doi: 10.3109/07357907.2011.605412. Epub 2011 Aug 30. Cancer Invest. 2011. PMID: 21877938 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,811 results

Search Page

Filters